Roche report strong Q1 results

A recent announcement of Q1 results look very favourable for Roche.

The Roche Group recorded total sales of 11.6 billion Swiss francs in the first quarter of 2009, an increase of 8% in local currencies (7% in Swiss francs; -1% in US dollars) compared with the year-earlier period. Growth was driven mainly by continued strong sales of key products in the Group’s oncology, virology, ophthalmology and inflammation portfolios, and of Roche Diagnostics’ immunoassay systems.


Posted in: General, News
CK Logo in place of featured image